[go: up one dir, main page]

EP0252940A4 - Arn anti-detection pour le traitement de maladies retrovirales. - Google Patents

Arn anti-detection pour le traitement de maladies retrovirales.

Info

Publication number
EP0252940A4
EP0252940A4 EP19870900464 EP87900464A EP0252940A4 EP 0252940 A4 EP0252940 A4 EP 0252940A4 EP 19870900464 EP19870900464 EP 19870900464 EP 87900464 A EP87900464 A EP 87900464A EP 0252940 A4 EP0252940 A4 EP 0252940A4
Authority
EP
European Patent Office
Prior art keywords
treatment
retroviral diseases
detection rna
rna
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19870900464
Other languages
German (de)
English (en)
Other versions
EP0252940A1 (fr
Inventor
Paul E Neiman
Richard Yue-Leung To
Shane C Booth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fred Hutchinson Cancer Center
Original Assignee
Fred Hutchinson Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fred Hutchinson Cancer Center filed Critical Fred Hutchinson Cancer Center
Publication of EP0252940A1 publication Critical patent/EP0252940A1/fr
Publication of EP0252940A4 publication Critical patent/EP0252940A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19870900464 1985-12-05 1986-11-26 Arn anti-detection pour le traitement de maladies retrovirales. Withdrawn EP0252940A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80597685A 1985-12-05 1985-12-05
US805976 1985-12-05

Publications (2)

Publication Number Publication Date
EP0252940A1 EP0252940A1 (fr) 1988-01-20
EP0252940A4 true EP0252940A4 (fr) 1989-07-27

Family

ID=25193005

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19870900464 Withdrawn EP0252940A4 (fr) 1985-12-05 1986-11-26 Arn anti-detection pour le traitement de maladies retrovirales.

Country Status (3)

Country Link
EP (1) EP0252940A4 (fr)
JP (1) JPS63501923A (fr)
WO (1) WO1987003451A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751181A (en) * 1984-12-31 1988-06-14 Duke University Methods and compositions useful in the diagnosis and treatment of autoimmune diseases
EP0477994B1 (fr) * 1985-03-21 2001-06-13 Johnston, Stephen, Ph.D. Résistance dérivée de parasite
AU612972B2 (en) * 1986-04-02 1991-07-25 Pioneer Hi-Bred International, Inc. Virus resistant plants having antisense rna
US5637573A (en) * 1986-05-23 1997-06-10 Agrawal; Sudhir Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions
US5194428A (en) * 1986-05-23 1993-03-16 Worcester Foundation For Experimental Biology Inhibition of influenza virus replication by oligonucleotide phosphorothioates
DE3853139T2 (de) * 1987-06-26 1995-06-14 Syntro Corp Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
US5110802A (en) * 1987-07-14 1992-05-05 City Of Hope Oligonucleotide phosphonates and method of inhibiting a human immunodeficiency virus in vitro utilizing said oligonucleotide phosphonates
CA1340843C (fr) * 1987-07-31 1999-12-07 J. Lawrence Burg Amplification selective de sequences polynucleotidiques cibles
FR2622207B1 (fr) * 1987-10-21 1990-03-09 Agronomique Inst Nat Rech Vecteurs d'integration et d'expression d'un gene heterologue, cellules infectees avec ces vecteurs et procede de production d'une proteine ou de modification genetique d'animaux
US5580761A (en) * 1988-02-16 1996-12-03 Greatbatch Gen-Aid Ltd. Method of conferring resistance to immunodeficiency viral infection
DE68929343T2 (de) * 1988-02-16 2002-09-12 Greatbatch Gen-Aid, Ltd. Modifizierte Zellen mit Resistenz gegen Retroviralinfektionen
ATE132190T1 (de) * 1988-02-26 1996-01-15 Worcester Found Ex Biology Hemmung von htlv-iii durch exogene oligonukleotide
GB8827592D0 (en) * 1988-11-25 1988-12-29 Taniguchi T Improvements in & relating to regulation of expression
GB8901778D0 (en) * 1989-01-27 1989-03-15 Univ Court Of The University O Manipulatory technique
US5087617A (en) * 1989-02-15 1992-02-11 Board Of Regents, The University Of Texas System Methods and compositions for treatment of cancer using oligonucleotides
FI924964L (fi) * 1990-05-04 1992-11-03 Isis Pharmaceuticals Inc Modulering av genexpression genom stoerande inverkan pao sekundaerstrukturen hos rna
NZ241310A (en) * 1991-01-17 1995-03-28 Gen Hospital Corp Trans-splicing ribozymes
NZ314630A (en) * 1991-01-17 2000-11-24 Harvard College Use of trans-splicing ribozymes for genetic modification and cell ablation in a host cell
PT1486211E (pt) 1993-04-30 2009-02-02 Wellstat Biologics Corp Composições para tratamento do cancro utilizando vírus
US6010904A (en) * 1995-06-07 2000-01-04 The General Hospital Corporation Cell ablation using trans-splicing ribozymes
US6776986B1 (en) 1996-06-06 2004-08-17 Novartis Ag Inhibition of HIV-1 replication by antisense RNA expression

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983001451A1 (fr) * 1981-10-23 1983-04-28 Molecular Biosystems Inc Agent therapeutique d'oligonucleotide et ses procedes de fabrication
WO1986005516A1 (fr) * 1985-03-21 1986-09-25 Duke University Resistance derivee d'un parasite
WO1987007300A2 (fr) * 1986-05-23 1987-12-03 Worcester Foundation For Experimental Biology Inhibition de l'htlv-iii par des oligonucleotides exogenes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5813909B2 (ja) * 1979-12-20 1983-03-16 株式会社トスカ 係止片群
JPS6024009B2 (ja) * 1980-09-11 1985-06-11 株式会社トスカ 取付部片集合体

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983001451A1 (fr) * 1981-10-23 1983-04-28 Molecular Biosystems Inc Agent therapeutique d'oligonucleotide et ses procedes de fabrication
WO1986005516A1 (fr) * 1985-03-21 1986-09-25 Duke University Resistance derivee d'un parasite
WO1987007300A2 (fr) * 1986-05-23 1987-12-03 Worcester Foundation For Experimental Biology Inhibition de l'htlv-iii par des oligonucleotides exogenes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8703451A1 *

Also Published As

Publication number Publication date
JPS63501923A (ja) 1988-08-04
EP0252940A1 (fr) 1988-01-20
WO1987003451A1 (fr) 1987-06-18

Similar Documents

Publication Publication Date Title
EP0252940A4 (fr) Arn anti-detection pour le traitement de maladies retrovirales.
FI874671A0 (fi) Anordning foer foerhindrande av laeckage i tryckledningar.
DE3887353D1 (de) Behandlungsverfahren für magen-darm-krankheiten.
IT8622281A0 (it) Metodi per la preparazione di medicazioni.
DE3884956D1 (de) Klärverfahren.
BR8502392A (pt) Tratamento de efluente
NO884617D0 (no) Krakkingsprosess.
FI875020L (fi) Terapeutiska aemnen.
DE3851682D1 (de) Targetformer von Antitumor-Methyltrithioagenzien.
DE3883325D1 (de) Lammellierter koerper von metallblechen.
IT8621294A0 (it) Procedimento di preparazione di monosialoganglioside.
FI871112L (fi) Terapeutiska aemnen.
NO864869D0 (no) Fremgangsmaate for fremstilling av ikke-aromatiske fluorallylamin mao-inhibitorer.
OA08406A (fr) Préparation de combinaison pour le traitement de la malaria.
IT8722448A0 (it) Fanghi di raffineria. procedimento per il trattamento di
IT8721560A0 (it) Procedimento per la purificazione di interferone.
FI870944L (fi) Ytbehandlingsfoerfarande.
FI885521L (fi) Elektriskt fordon.
FR2654822B1 (fr) Dispenseur de sous-projectiles.
FI865220A7 (fi) Menetelmä sulfinyyli- ja sulfonyylisubstituoitujen 3-bentsatsepiinien valmistamiseksi.
MX162258A (es) Procedimiento de preparacion de acidos dihidro-5,6-4h-ciclopenta/b/tiofencarboxilicos-6
ES2017485B3 (es) Proceso para la preparacion de alfa-n-(hipoxantin-9il)pentiloxi-carbonil-arginina.
MX12003A (es) Procedimiento para la preparacion de composicionesherbicidas.
DZ1358A1 (fr) Composition pour le traitement de leishmanioses.
FI863085A7 (fi) Menetelmä alkyyli-2-alkoksikarbonyyli- -3,4-dialkoksibentseenikarbamaattien valmistamiseksi.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19871119

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19890727

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19910601

RIN1 Information on inventor provided before grant (corrected)

Inventor name: TO, RICHARD, YUE-LEUNG

Inventor name: NEIMAN, PAUL, E.

Inventor name: BOOTH, SHANE, C.